About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Quarterly Shareholder Update
July 1, 2015
Click here to read more
Post navigation
Previous Post
Apppointment of Consultant to Assist in Commercialising TPM for the Mass Market
Next Post
Phosphagenics Director and Founder Steps Down
Related Posts
Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan
January 31, 2017
Phosphagenics Signs Development Agreement for TPM Oxymorphone Patch in Japan
August 22, 2017
Avecho reaches two-year stability milestone for its CBD softgel capsule
June 22, 2023
June 22, 2023